UCLA Clinical and Translational Science Institute (UCLA CTSI) Clinical and Translational Science Award

UCLA Clinical and Translational Science Institute (UCLA CTSI) Clinical and Translational Science Award

Funder: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

Award Amount: $59 million

Award Type: Clinical and Translational Science Award (CTSA)

Overview

The UCLA CTSI is a research partnership among UCLA, Charles R. Drew University of Medicine and Science, the Lundquist Institute at Harbor-UCLA Medical Center, and Cedars-Sinai Medical Center. It is one of 60 member institutions in the NCATS consortium established to accelerate the translation of scientific discoveries into effective health interventions that improve clinical care.

Focus Areas

• Health equity through research
• Elimination of health disparities
• Diverse health science research
• Translation of scientific discoveries into clinical practice
• Community collaborations
• Interdisciplinary research (engineering, business, public health)

Recent Achievements

• Supported more than 200 basic, clinical, and translational studies during COVID-19 pandemic response
• Supported more than 2,100 researchers
• Important discoveries related to lung cancer and breast cancer
• Trained more than 1,080 junior faculty, postdoctoral scholars, graduate and healthcare professional students, undergraduates and research staff

Geographic Scope

• Los Angeles County

Contact Information

• Institution: Charles R. Drew University of Medicine and Science, 1731 E. 120th St., Los Angeles, CA 90059
• Phone: (323) 563-4800